HIMSS TV
Susan Conover, the digital health company's cofounder and CEO, discusses its AI-enabled dermatology tool, a recent $6 million raise and its plan to scale its reach and expand its partnerships across healthcare.
Frank Forte, CEO of Anatomy IT, discusses how the company uses AI tools to proactively detect and flag cyber threats for healthcare clients so those threats can be quickly remediated before patient care is disrupted.
Dr. Nele Jessel, athenahealth's CMO and Dr. Andrew Mellin, Surescripts' VP and CMIO, said that real-time prescription benefit data has helped patients avoid sticker shock, save money and pick up 8% more scripts across athena's prescribers.
InteliChart's platform can integrate with EHRs and engage with patients via their preferred means. This allows providers to focus on clinical workflows, says Will Cantrell, the company's director of product solutions.
Mindy Bosanek, the health system's director of surgical services, and Cynthia Harms, its surgical services OR business manager, say being able to deliver a "single source of truth" has freed up a surgery schedule that was 90% blocked.
Hannes Klöpper, cofounder and CEO of HelloBetter, says the U.S. health system is a convoluted array of institutions. But using DTx is one way to lower barriers to care and improve cost efficiency and access.
University Hospital Chief Information Officer Paul Contino, who serves as chair of the HIMSS global health education committee, discusses chapter involvement and networking, and explains how it has helped him grow and advance over 20 years.
Research teams work to prevent bias in algorithms by involving clinicians and partnering with established AI companies, says Dr. Alexander Ryu, vice chair of AI and innovation at Mayo Clinic.
ZeOmega uses AI to identify vulnerable patient populations and suggest ways to improve their health outcomes. Pravin Pant, the company's VP of advanced analytics, and Michael Gould, its associate VP of interoperability strategy, explain.
Aytan Dahukey, partner and leader of Sheppard Mullin's private equity team, says there's a lot of cash ready to deploy – but private equity buyers need sellers who have realistic value expectations.